Page last updated: 2024-08-25

atovaquone and P carinii Pneumonia

atovaquone has been researched along with P carinii Pneumonia in 105 studies

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	63 (60.00)	18.2507
2000's	21 (20.00)	29.6817
2010's	15 (14.29)	24.3611
2020's	6 (5.71)	2.80

Authors

Authors	Studies
Hagihara, M; Hanai, H; Inoue, M; Kushi, R; Mita, M; Sugi, T; Uchida, T	1
Devaraj, S; Horvath, TD	1
Chaudhry, A; Dabas, R; Daly, A; Dharmani-Khan, P; Dowhan, M; Duggan, P; Evernden, C; Gregson, D; Jamani, K; Jimenez-Zepeda, V; Johnson, A; Jupp, J; Kalra, A; Khan, F; Storek, J; Tay, J	1
Booth, J; Chowdary, P; Khurram, MA; Mohamed, IH; Shetty, S; Yaqoob, M	1
Adeojo, LW; Alfaro, R; Ashbaugh, A; Cushion, MT; Kovacs, JA; Kumar, P; Lu, R; Mannino, R; Tramont, E	1
Akashi, K; Jinno, S; Nose, Y; Onishi, A; Saegusa, J; Yamashita, M	1
Argy, N; Dorent, R; Houze, S; Le Gal, S; Le, MP; Lescure, FX; Lucet, JC; Massias, L; Nevez, G; Vindrios, W; Wolff, M; Yazdanpanah, Y	1
Beckerich, F; Cordonnier, C; Hulin, A; Khoudour, N; Lê, MP; Leclerc, M; Massias, L; Maury, S; Melica, G; Redjoul, R; Robin, C	1
Barr, VO; Galal, A; McLaughlin, MM; Mitchell, P; Patel, N; Richardson, CL; Stosor, V; Sutton, SH	1
Argy, N; Clain, J; Coppée, R; Houzé, S; Hunte, C; Kao, WC; Le Gal, S; Lucet, JC; Massias, L; Nevez, G; Song, Z; Vindrios, W; Yazdanpanah, Y	1
Molina, A; Pan, D; Schiller, GJ; Winston, DJ	1
Asagiri, T; Nakamura, M; Okazaki, M; Takeuchi, S	1
Beckerich, F; Botterel, F; Cabanne, L; Cordonnier, C; di Blasi, R; Foulet, F; Leclerc, M; Maury, S; Pautas, C; Redjoul, R; Robin, C; Toma, A	1
Asako, K; Kikuchi, H; Kitazawa, T; Kono, H; Ota, Y; Seo, K; Yoshino, Y	1
Bejjanki, H; Koratala, A; Olaoye, OA; Santos, AH	1
Fukutake, K; Sekine, Y; Shinozawa, K; Yamamoto, Y; Yotsumoto, M	1
Anwer, F; Diri, R; Krishnadasan, R; McBride, A; Yeager, A	1
Alfaro, RM; Calderón, MM; Kovacs, JA; Kumar, P; McManus, M; Pau, AK; Penzak, SR	1
Cockfield, S; Gourishankar, S; Humar, A; Kumar, D; Mueller, T; Vethanayagam, D; Weinkauf, J	1
Takahashi, T	1
Bellamy, RJ	1
Andrianakis, I; Betrosian, AP; Douzinas, EE; Flevari, K	1
Dean, SR; Hidalgo, K; Lyles, A	1
Borde, JP; de With, K; Offensperger, WB	1
James, CW; McNelis, KC; Szabo, S	1
Fishman, JA; Rodriguez, M; Sifri, CD	1
Ioannidis, J; Wilkinson, D	2
Dankner, WM; Flores, MA; Huang, S; Hughes, WT; Kline, MW; Paul, ME; Wei, LJ; Yogev, R	1
Bellamy, R	3
Czerwionka-Szaflarska, M; Gospodarek, E; Powierska-Czarny, J	1
Kessl, JJ; Meshnick, SR; Trumpower, BL	1
Cantrill, HL; Holland, EJ; Shah, GK	1
Goa, KL; Spencer, CM	1
Hughes, WT; LaFon, SW; Masur, H; Scott, JD	1
Comley, JC; Sterling, AM	1
Andrews, E; Brown, N; LaFon, S; Rogers, M; White, A	1
Lederman, MM; van der Horst, C	1
Stoeckle, M; Tennenberg, A	1
Hughes, WT	3
Caldwell, PT; Deresinski, SC; Dohn, MN; Follansbee, SE; Gathe, JC; Haghighat, DP; Lancaster, DJ; Meyer, RD; Sampson, JH; Scott, JD; Spotkov, J; Torres, RA; Weinberg, WG	1
Lizasoain, M; Lumbreras, C; Pastor, C	1
Daar, ES; Epstein, LJ; Meyer, RD; Mohsenifar, Z; Yeh, V	1
Fisher, MJ; Gazzard, BG; Hawkins, DA; Nelson, MR	1
Artymowicz, RJ; James, VE	1
Flaherty, JF; Haile, LG	1
Finley, R	1
Bozzette, SA; Chan, C; Clumeck, N; Frame, P; Hughes, W; Kramer, F; Lancaster, D; Leoung, G; Masur, H; Safrin, S	1
Fish, DN; Goodwin, SD	1
Bogner, JR; Goebel, FD	1
Balducci, M; Burzacchini, F; Cirioni, O; Giacometti, A; Scalise, G	1
Korraa, H; Saadeh, C	1
Comley, JC; Frend, TJ; Yeates, CL	1
Hansson, AG; Jatlow, P; Mitchell, S; Rainey, PM	1
Angelici, E; Canipari, R; Colombo, D; Contini, C; Cultrera, R; Prini, E; Sechi, T	1
Byrd, JC; Cragun, WH; Hargis, JB; Kester, KE; Rearden, TP; Zacher, LL	1
McKendrick, MW; Nash, C; Vilar, FJ	1
Deresinski, SC	1
Davis, C; Freeze, T; Hughes, WT; LaFon, S; Pattishall, E; Rogers, M; Sillos, EM; Snyder, G; Staton, S; Studenberg, S; Woolley, JL	1
Fishman, JA	2
Beauchamp, B; Dorenbaum, A; Hughes, W; McNamara, J; Moye, J; Purdue, L; Rogers, M; Sadler, B; van Dyke, R; Xu, J; Yogev, R	1
Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC	1
Bartlett, MS; Baughman, RP; Dohn, MN; Hossler, PA; Kazanjian, P; Meshnick, SR; Miller, RF; Smith, JW; Wakefield, AE; Walker, DJ	1
Bryan, E; McFarland, J; Sackoff, J; Su, S	1
Balfour, HH; Cheung, TW; El-Sadr, WM; Eng, R; Hafner, R; Hooton, TM; Kerkering, TM; Luskin-Hawk, R; Murphy, RL; Schutz, M; van der Horst, C; Yurik, TM	1
Castro, M	1
Bala, MV; Bennett, CL; Dohn, MN; Simpson, K; Wood, LL; Zarkin, GA	1
Horowitz, HW; Wormser, GP	1
Caldwell, P; Chan, C; Dohn, M; Lefebvre, EA; Marina, R; McIvor, RA; Montaner, J; Morey, G; Scott, J	1
Cheung, TW	1
Colby, C; Finkelstein, D; Fishman, J; McAfee, S; Sackstein, R; Spitzer, T	1
Bechtel, C; Davey, RT; Falloon, J; Kovacs, JA; LaFon, SW; Lane, HC; Masur, H; Piscitelli, SC; Polis, MA; Sadler, B; Sargent, S; Walker, RE	1
Armstrong, W; Beard, CB; Burman, W; Carter, J; Crane, L; Duchin, J; Hossler, PA; Huang, L; Kazanjian, P; Lee, CH; Meshnick, SR; Richardson, J	1
Braun, J; Caldwell, PT; Chan, CK; Dohn, MN; McCarthy, W; Montaner, J; Rosenberg, DM; Slavinsky, J	1
Chaloner, K; Rhame, FS	1
Angelici, E; Canipari, R; Contini, C	1
Walker, MJ	1
Cotton, D	1
Cadman, J; Torres, G	1
Borrego, F; Meyers, B; Papanicolaou, G	1
Groll, AH; Müller, FM; Ritter, J	1
Gill, VJ; Kovacs, JA; Masur, H; Meshnick, S	1
Baggish, AL; Hill, DR	1
Cohen, CJ; Craven, DE; Freedberg, KA; Goldie, SJ; Kaplan, JE; Kimmel, AD; Losina, E; Paltiel, AD; Seage, GR; Weinstein, MC; Zhang, H	1
Masur, H	1
Davey, RT; Falloon, J; Feuerstein, I; Hughes, W; Kovacs, J; LaFon, S; Lancaster, D; O'Neill, D; Polis, M; Rogers, M	1
Flynn, PM; Fullen, G; Hetherington, SV; Hughes, WT; Kennedy, W; Lancaster, DJ; Palte, S; Rosenbaum, D; Shenep, JL; Stein, DS	1
Gray, VL; Gutteridge, WE; Hughes, WT; Latter, VS; Pudney, M	1

Reviews

25 review(s) available for atovaquone and P carinii Pneumonia

Article	Year
Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-HIV Agents; Atovaquone; CD4 Lymphocyte Count; CD4-CD8 Ratio; COVID-19; Dideoxynucleosides; Female; Glucocorticoids; Graft Rejection; HIV Infections; HIV-1; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Raltegravir Potassium; RNA, Viral; SARS-CoV-2; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination	2021
[Mutations of drug target molecules in Pneumocystis jirovecii isolates and future investigations]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:2 Topics: Adult; Aged; Atovaquone; Dihydropteroate Synthase; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Mutation; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2009
HIV: treating Pneumocystis pneumonia (PCP). BMJ clinical evidence, 2008, Jul-16, Volume: 2008 Topics: Administration, Oral; Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Atovaquone; HIV Infections; Humans; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2008
[Diagnosis and treatment of pneumocystis jirovecii pneumonia]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:27 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Bronchoalveolar Lavage Fluid; Caspofungin; Diagnosis, Differential; Echinocandins; Humans; Lipopeptides; Lung; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate	2011
HIV: opportunistic infections. Clinical evidence, 2003, Issue:9 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine	2003
HIV: prevention of opportunistic infections. Clinical evidence, 2003, Issue:10 Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine	2003
Pneumocystis carinii pneumonia treatment in people infected with HIV. Clinical evidence, 2004, Issue:11 Topics: Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	2004
[New aspects of epidemiology and treatment of Pneumocystis carinii infection]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:101 Topics: Anti-Infective Agents; Antifungal Agents; Atovaquone; Drug Resistance, Multiple, Fungal; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Pneumocystis pneumonia in people with HIV. Clinical evidence, 2005, Issue:13 Topics: Atovaquone; Clindamycin; Corticosterone; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	2005
Pneumocystis pneumonia in people with HIV. Clinical evidence, 2006, Issue:15 Topics: Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. Trends in parasitology, 2007, Volume: 23, Issue:10 Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Atovaquone; Electron Transport Complex III; Enzyme Inhibitors; Humans; Malaria, Falciparum; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Pneumocystis carinii; Pneumonia, Pneumocystis; Sequence Alignment; Toxoplasma; Toxoplasmosis; Yeasts	2007
Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs, 1995, Volume: 50, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis	1995
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Mar-01, Volume: 8, Issue:3 Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination	1995
[Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS]. Medicina clinica, 1994, Oct-15, Volume: 103, Issue:12 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimetrexate	1994
Atovaquone: a new antipneumocystis agent. Clinical pharmacy, 1993, Volume: 12, Issue:8 Topics: Antifungal Agents; Atovaquone; Drug Costs; Drug Interactions; Food; Humans; Intestinal Absorption; Naphthoquinones; Pneumonia, Pneumocystis	1993
Atovaquone: a review. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:12 Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Trials as Topic; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis, Cerebral	1993
[Therapy and prevention of pneumocystis carinii pneumonia]. Der Internist, 1995, Volume: 36, Issue:12 Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Dapsone; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole. Southern medical journal, 1996, Volume: 89, Issue:3 Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Humans; Leucovorin; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate	1996
Treatment of Pneumocystis carinii pneumonia in adults with AIDS. Seminars in respiratory infections, 1997, Volume: 12, Issue:2 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Humans; Infusions, Intravenous; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate	1997
Prevention of infection due to Pneumocystis carinii. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5 Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Fungal Vaccines; Humans; Microbial Sensitivity Tests; Naphthoquinones; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; Trimethoprim, Sulfamethoxazole Drug Combination	1998
Treatment of infection due to Pneumocystis carinii. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Macrolides; Naphthoquinones; Pentamidine; Pneumocystis; Pneumocystis Infections; Pneumonia, Pneumocystis; Pyrimidines; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate	1998
Treatment and prophylaxis of Pneumocystis carinii pneumonia. Seminars in respiratory infections, 1998, Volume: 13, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clinical Trials as Topic; Dapsone; Female; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	1998
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer]. Klinische Padiatrie, 2001, Volume: 213 Suppl 1 Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Naphthoquinones; Neoplasms; Odds Ratio; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Antiparasitic agent atovaquone. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5 Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Babesia; Humans; Naphthoquinones; Plasmodium; Pneumocystis; Pneumonia, Pneumocystis; Protozoan Infections; Randomized Controlled Trials as Topic; Toxoplasma	2002
Prophylaxis and therapy for Pneumocystis pneumonia--where are we? Infectious agents and disease, 1992, Volume: 1, Issue:5 Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Drug Tolerance; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination	1992

Trials

17 trial(s) available for atovaquone and P carinii Pneumonia

Article	Year
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-15, Volume: 62, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Infective Agents; Atazanavir Sulfate; Atovaquone; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Encephalitis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Ritonavir; Toxoplasmosis, Cerebral; Young Adult	2016
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1 Topics: Adolescent; AIDS-Related Opportunistic Infections; Atovaquone; Azithromycin; Bacterial Infections; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2005
Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. The Journal of infectious diseases, 1995, Volume: 171, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Jul-01, Volume: 9, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Child; Child, Preschool; Drugs, Investigational; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis	1995
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Mar-01, Volume: 8, Issue:3 Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group. Annals of internal medicine, 1994, Aug-01, Volume: 121, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Survival Analysis; Treatment Outcome	1994
Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia. The American journal of the medical sciences, 1994, Volume: 308, Issue:1 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Outcome	1994
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. The New England journal of medicine, 1993, May-27, Volume: 328, Issue:21 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthoquinones; Odds Ratio; Pneumonia, Pneumocystis; Regression Analysis; Trimethoprim, Sulfamethoxazole Drug Combination	1993
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Child; Child, Preschool; Humans; Infant; Naphthoquinones; Pneumonia, Pneumocystis	1998
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Dec-01, Volume: 19, Issue:4 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service	1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Grou The New England journal of medicine, 1998, Dec-24, Volume: 339, Issue:26 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Female; Follow-Up Studies; HIV Infections; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1998
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia. PharmacoEconomics, 1996, Volume: 9, Issue:6 Topics: Antifungal Agents; Atovaquone; Costs and Cost Analysis; Decision Trees; Humans; Injections, Intravenous; Monte Carlo Method; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis	1996
Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. The Journal of infectious diseases, 1999, Volume: 180, Issue:2 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim	1999
A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone marrow transplantation, 1999, Volume: 24, Issue:8 Topics: Adult; Aged; Antifungal Agents; Atovaquone; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Naphthoquinones; Neoplasms; Pneumocystis; Pneumonia, Pneumocystis; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study. Pharmacotherapy, 1999, Volume: 19, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Fasting; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1999
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. The New England journal of medicine, 1991, Nov-28, Volume: 325, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Atovaquone; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Partial Pressure; Pneumonia, Pneumocystis; Recurrence; Treatment Outcome	1991
Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. The Journal of infectious diseases, 1991, Volume: 163, Issue:4 Topics: Adult; Antifungal Agents; Atovaquone; Cohort Studies; Drug Evaluation; Drug Tolerance; Half-Life; HIV Infections; Homosexuality; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis	1991

Other Studies

64 other study(ies) available for atovaquone and P carinii Pneumonia

Article	Year
Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone. International journal of clinical pharmacology and therapeutics, 2023, Volume: 61, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Atovaquone; Hematologic Diseases; Humans; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination	2023
Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients. Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737 Topics: Antifungal Agents; Atovaquone; Child; Chromatography, Liquid; Humans; Leukemia, Myeloid, Acute; Plant Extracts; Pneumonia, Pneumocystis; Tandem Mass Spectrometry	2024
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. Cytotherapy, 2020, Volume: 22, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antilymphocyte Serum; Atovaquone; CD4 Lymphocyte Count; Dapsone; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Lymphopenia; Male; Middle Aged; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2020
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia. The Journal of infectious diseases, 2021, 07-15, Volume: 224, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Atovaquone; Disease Models, Animal; Mice; Pneumonia, Pneumocystis	2021
Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids. Rheumatology international, 2022, Volume: 42, Issue:8 Topics: Atovaquone; Connective Tissue Diseases; Glucocorticoids; Humans; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 10-01, Volume: 65, Issue:7 Topics: Adult; Aged; Atovaquone; Chemoprevention; Cross Infection; Disease Outbreaks; Female; Genotype; Heart Transplantation; Humans; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	2017
Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii. The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Aged; Antifungal Agents; Atovaquone; Biological Availability; Female; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis	2017
Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:6 Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Atovaquone; Drug Substitution; Humans; Kidney Transplantation; Pneumocystis carinii; Pneumonia, Pneumocystis; Postoperative Complications; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2017
Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 08-31, Volume: 67, Issue:6 Topics: Adult; Aged; Antifungal Agents; Atovaquone; Computer Simulation; Cytochromes b; Disease Outbreaks; Female; Fungal Proteins; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Models, Molecular; Mutation; Pneumocystis carinii; Pneumonia, Pneumocystis; Transplant Recipients; Treatment Failure	2018
Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:8 Topics: Adult; Aged; Allografts; Atovaquone; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Nocardia Infections; Pneumonia, Pneumocystis; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Consecutive hypoglycemia attacks induced by co-trimoxazole followed by pentamidine in a patient with acquired immunodeficiency syndrome. International journal of STD & AIDS, 2019, Volume: 30, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Aged; Anti-Infective Agents; Atovaquone; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemia; Pentamidine; Pneumonia, Pneumocystis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2019
Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines? Bone marrow transplantation, 2019, Volume: 54, Issue:7 Topics: Adult; Aged; Allografts; Atovaquone; Drug Combinations; Female; Follow-Up Studies; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Sulfadoxine; Trimethoprim	2019
Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:5 Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Asthma; Atovaquone; Connective Tissue Diseases; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2019
Liver transplant, toxoplasmosis and kidney stones: connecting the dots. BMJ case reports, 2019, Feb-15, Volume: 12, Issue:2 Topics: Aftercare; Antimalarials; Antiprotozoal Agents; Atovaquone; Brain; Brain Edema; Female; Humans; Kidney Calculi; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Sulfadiazine; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography	2019
[Status of use and side effects of atovaquone for the treatment and prevention of pneumocystis pneumonia in HIV infected patients in Japan--from 1997 to 2012--The Clinical Study Group for AIDS Drugs, supported by Health and Labor Science Grants from the M Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2013, Volume: 87, Issue:4 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Humans; Male; Middle Aged; Pneumonia, Pneumocystis	2013
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2016
Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:2 Topics: Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Atovaquone; Female; Graft Rejection; Humans; Immunologic Factors; Injections, Intravenous; Kidney Transplantation; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Postoperative Complications; Radiography; Rituximab; Tomography Scanners, X-Ray Computed; Treatment Outcome; Trimethoprim	2009
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. Scandinavian journal of infectious diseases, 2010, Volume: 42, Issue:1 Topics: Administration, Oral; Anti-Infective Agents; Atovaquone; Cytomegalovirus Infections; Female; Glucosephosphate Dehydrogenase; Humans; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Treatment Outcome	2010
A potential interaction between warfarin and atovaquone. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:1 Topics: AIDS-Related Opportunistic Infections; Anticoagulants; Antifungal Agents; Atovaquone; Drug Interactions; Drug Monitoring; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Pulmonary Embolism; Risk Factors; Venous Thrombosis; Vitamin K; Warfarin	2011
Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Aug-01, Volume: 60, Issue:15 Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Atovaquone; Clinical Protocols; Dapsone; Drug Therapy, Combination; HIV Infections; Hospital Administration; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Retreatment; Trimethoprim, Sulfamethoxazole Drug Combination	2003
Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-15, Volume: 38, Issue:8 Topics: Aged; Antifungal Agents; Atovaquone; Chemoprevention; Humans; Liver Transplantation; Male; Middle Aged; Naphthoquinones; Opportunistic Infections; Pneumocystis carinii; Pneumonia, Pneumocystis; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination	2004
Vortex keratopathy associated with atovaquone. American journal of ophthalmology, 1995, Volume: 120, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Cornea; Corneal Diseases; Epithelium; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis	1995
Drugs for AIDS and associated infections. The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine	1995
Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4 Topics: Animals; Antifungal Agents; Atovaquone; Dapsone; Drug Therapy, Combination; Mice; Mice, SCID; Naphthoquinones; Pneumonia, Pneumocystis; Proguanil; Rifabutin; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Atovaquone for Pneumocystis carinii pneumonia. Annals of internal medicine, 1995, Feb-15, Volume: 122, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Failure	1995
Atovaquone for Pneumocystis carinii pneumonia. Annals of internal medicine, 1995, Feb-15, Volume: 122, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Failure	1995
Atovaquone as prophylaxis against Pneumocystis carinii pneumonia. The Journal of infection, 1994, Volume: 28, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Immunocompromised Host; Naphthoquinones; Pneumonia, Pneumocystis	1994
Deceptive X-ray films in an advertisement. The New England journal of medicine, 1993, Oct-14, Volume: 329, Issue:16 Topics: Advertising; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Radiography; X-Ray Film	1993
Atovaquone: a new oral treatment for pneumocystis. The Nurse practitioner, 1993, Volume: 18, Issue:9 Topics: Antifungal Agents; Atovaquone; Biological Availability; Drug Costs; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1993
Atovaquone for Pneumocystis carinii pneumonia. The Medical letter on drugs and therapeutics, 1993, Apr-02, Volume: 35, Issue:893 Topics: Antifungal Agents; Atovaquone; Clinical Trials as Topic; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1993
Mepron for AIDS-related pneumonia. American pharmacy, 1993, Volume: NS33, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Drug Approval; Humans; Naphthoquinones; Pneumonia, Pneumocystis; United States; United States Food and Drug Administration	1993
Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia. Clinical pharmacy, 1993, Volume: 12, Issue:3 Topics: Administration, Oral; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1993
Criteria for use of atovaquone oral suspension in adult inpatients and outpatients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Nov-01, Volume: 52, Issue:21 Topics: Administration, Oral; Adult; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Protocols; Drug Monitoring; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis, Cerebral	1995
In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Microbial Sensitivity Tests; Naphthalenes; Naphthoquinones; Pneumocystis; Pneumonia, Pneumocystis; Terbinafine; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Antipneumocystis activity of 17C91, a prodrug of atovaquone. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:10 Topics: Animals; Antifungal Agents; Atovaquone; Carbamates; Female; Mice; Mice, SCID; Naphthoquinones; Pneumonia, Pneumocystis; Prodrugs	1995
Rapid high-performance liquid chromatographic assay for atovaquone. Journal of chromatography. B, Biomedical applications, 1996, Jan-12, Volume: 675, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Chromatography, High Pressure Liquid; Naphthoquinones; Pneumonia, Pneumocystis; Reproducibility of Results; Spectrophotometry, Ultraviolet	1996
Employment of terbinafine against Pneumocystis carinii infection in rat models. The British journal of dermatology, 1996, Volume: 134 Suppl 46 Topics: Administration, Oral; Albendazole; Animals; Antifungal Agents; Atovaquone; Drug Administration Schedule; Immunosuppression Therapy; Lung; Naphthalenes; Naphthoquinones; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Terbinafine; Trimethoprim, Sulfamethoxazole Drug Combination	1996
Granulomatous Pneumocystis carinii pneumonia in patients with low-grade lymphoid malignancies: a diagnostic dilemma. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:6 Topics: Aged; Anti-Infective Agents, Urinary; Atovaquone; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Granuloma; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Pseudolymphoma	1996
Atovaquone as prophylaxis for Pneumocystis carinii. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Female; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1996
Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia. The Journal of infectious diseases, 1998, Volume: 177, Issue:4 Topics: Administration, Inhalation; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Atovaquone; Dexamethasone; Drug Therapy, Combination; Lung; Male; Naphthoquinones; Pneumonia, Pneumocystis; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Trimethoprim, Sulfamethoxazole Drug Combination	1998
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Morbidity; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; United States	1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. The Journal of infectious diseases, 1998, Volume: 178, Issue:6 Topics: Amino Acid Sequence; Animals; Antifungal Agents; Atovaquone; Cytochrome b Group; DNA Primers; Evolution, Molecular; Humans; Lung; Mice; Molecular Sequence Data; Naphthoquinones; Phylogeny; Pneumocystis; Pneumonia, Pneumocystis; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Protein Binding; Rats; Saccharomyces cerevisiae; Sequence Alignment; Sequence Homology, Amino Acid; Treatment Failure	1998
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia. The New England journal of medicine, 1999, May-13, Volume: 340, Issue:19 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Drug Costs; HIV Infections; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1999
Overdose of atovaquone in a patient with AIDS. AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Drug Overdose; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1999
Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Atovaquone; Case-Control Studies; Cohort Studies; Cytochrome b Group; Female; Gene Amplification; Humans; Male; Middle Aged; Molecular Sequence Data; Naphthoquinones; Pneumocystis; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Survival; Treatment Outcome; Ubiquinone	2001
Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS (London, England), 2001, Jan-26, Volume: 15, Issue:2 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Naphthoquinones; Pharmaceutical Solutions; Pneumonia, Pneumocystis; Retrospective Studies; Tablets; Treatment Outcome	2001
Quantifying and documenting prior beliefs in clinical trials. Statistics in medicine, 2001, Feb-28, Volume: 20, Issue:4 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Attitude of Health Personnel; Bayes Theorem; Clinical Trials as Topic; Dapsone; Ethics, Medical; HIV Infections; Humans; Naphthoquinones; Physicians; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; Sample Size; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2 Topics: Animals; Antifungal Agents; Antigens, Fungal; Atovaquone; Blood; Blotting, Western; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Electrophoresis; Immunosuppression Therapy; Male; Naphthalenes; Naphthoquinones; Pneumocystis; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Survival Rate; Terbinafine; Trimethoprim, Sulfamethoxazole Drug Combination	1999
Opportunistic infections studies update. NIAID AIDS agenda, 1995,Spring Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasis; Clinical Trials as Topic; Cryptosporidiosis; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunotherapy; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Paromomycin; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis; Tuberculosis	1995
Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration. AIDS clinical care, 1995, Volume: 7, Issue:7 Topics: Antifungal Agents; Atovaquone; Biological Availability; Clinical Trials as Topic; Drug Approval; Humans; Naphthoquinones; Pneumonia, Pneumocystis; United States; United States Food and Drug Administration	1995
PCP prevention for children. Treatment review, 1995, Issue:no 18 Topics: Antifungal Agents; Atovaquone; Clinical Trials as Topic; Dapsone; HIV Infections; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; United States	1995
FDA approves new PCP drug. Food and Drug Administration. AIDS alert, 1995, Volume: 10, Issue:8 Topics: Antiviral Agents; Atovaquone; Chemistry, Pharmaceutical; Drug Approval; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Suspensions; Tablets; United States Food and Drug Administration	1995
Optimizing PCP therapy. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1997, Volume: 11, Issue:10 Topics: Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Encephalitis; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination	1997
Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:8 Topics: Antifungal Agents; Atovaquone; Bone Marrow; Drug Eruptions; Humans; Liver Transplantation; Naphthoquinones; Pneumonia, Pneumocystis; Postoperative Care; Prospective Studies; Retreatment; Trimethoprim, Sulfamethoxazole Drug Combination	2001
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA, 2001, Nov-21, Volume: 286, Issue:19 Topics: AIDS-Related Opportunistic Infections; Algorithms; Anti-Infective Agents; Atovaquone; Dihydropteroate Synthase; Drug Resistance, Fungal; Fungal Proteins; Humans; Lymphoma, AIDS-Related; Male; Membrane Glycoproteins; Middle Aged; Mutation; Naphthoquinones; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. Archives of internal medicine, 2002, Apr-22, Volume: 162, Issue:8 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; CD4 Lymphocyte Count; Cost-Benefit Analysis; Dapsone; Drug Costs; Humans; Life Expectancy; Models, Theoretical; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Quality-Adjusted Life Years	2002
New drug offers alternative treatment for PCP. American family physician, 1992, Volume: 46, Issue:4 Topics: AIDS-Related Opportunistic Infections; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1992
New oral agent for PCP is effective, well tolerated. Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:9 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
New AIDS drug available. AORN journal, 1992, Volume: 55, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
Treatment IND protocol announced for Pneumocystis carinii pneumonia. Clinical pharmacy, 1992, Volume: 11, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Clinical Protocols; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
AIDS-related treatment receives IND status. The Journal of the American Osteopathic Association, 1992, Volume: 92, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia. Annals of internal medicine, 1992, Jun-01, Volume: 116, Issue:11 Topics: Antifungal Agents; Atovaquone; HIV Infections; Humans; Naphthoquinones; Opportunistic Infections; Pneumonia, Pneumocystis	1992
FDA authorizes wider use of new oral medication for AIDS. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Atovaquone; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1991
Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:2 Topics: Animals; Anti-Infective Agents; Atovaquone; Dexamethasone; Lung; Male; Naphthoquinones; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination	1990